SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Andreas Brunschweiger, Pierre Koch, Miriam Schlenk, Felipe Pineda, Petra Küppers, Sonja Hinz, Meryem Köse, Stefan Ullrich, Jörg Hockemeyer, Michael Wiese, Jag Heer, Christa E. Müller, 8-Benzyltetrahydropyrazino[2,1-f]purinediones: Water-Soluble Tricyclic Xanthine Derivatives as Multitarget Drugs for Neurodegenerative Diseases, ChemMedChem, 2014, 9, 8
  2. 2
    Annalisa Pinna, Micaela Morelli, A Critical Evaluation of Behavioral Rodent Models of Motor Impairment Used for Screening of Antiparkinsonian Activity: The Case of Adenosine A2A Receptor Antagonists, Neurotoxicity Research, 2014, 25, 4, 392

    CrossRef

  3. 3
    Lihui Zhang, Tianjun Liu, Xia Wang, Jinan Wang, Guohui Li, Yan Li, Ling Yang, Yonghua Wang, Insight into the binding mode and the structural features of the pyrimidine derivatives as human A2A adenosine receptor antagonists, Biosystems, 2014, 115, 13

    CrossRef

  4. 4
    Anna Drabczyńska, Tadeusz Karcz, Ewa Szymańska, Meryem Köse, Christa E. Müller, Minka Paskaleva, Janina Karolak-Wojciechowska, Jadwiga Handzlik, Olga Yuzlenko, Katarzyna Kieć-Kononowicz, Synthesis, biological activity and molecular modelling studies of tricyclic alkylimidazo-, pyrimido- and diazepinopurinediones, Purinergic Signalling, 2013, 9, 3, 395

    CrossRef

  5. 5
    Klaus Roth, Erich Lück, Kalorienfreie Süße aus Labor und Natur, Chemie in unserer Zeit, 2012, 46, 3
  6. 6
    Anna Drabczynska, Malgorzata Zygmunt, Jacek Sapa, Barbara Filipek, Christa E. Mueller, Katarzyna Kiec-Kononowicz, ChemInform Abstract: Antiparkinsonian Effects of Novel Adenosine A2A Receptor Antagonists., ChemInform, 2011, 42, 17